本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

33.94
+1.314.01%
盤後33.940.00000.00%19:30 EDT
成交量:159.21萬
成交額:5,386.27萬
市值:42.58億
市盈率:-23.72
高:34.35
開:33.33
低:32.95
收:32.63
52周最高:41.14
52周最低:10.83
股本:1.25億
流通股本:1.10億
量比:0.92
換手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-1.4309
每股收益(LYR):-1.5305
淨資產收益率:-74.73%
總資產收益率:-44.13%
市淨率:17.80
市盈率(LYR):-22.18

資料載入中...

2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/04

重要事件披露

Form 8-K - Current report
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/11

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/08

重要事件披露

Form 8-K - Current report
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]